Navigation

Myelodysplastic syndrome - azacitidine: register to attend the appeal

The Institute has received four appeals against the Final Appraisal Determination and Guidance on this technology. The Institute has arranged the hearing for the appeals received against the FAD for the above technology. The appeal panel will convene on Tuesday 1st June 2010 to hear oral representations from the appellants.

This page was last updated: 22 April 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.